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aBStract
CONTEXT AND OBJECTIVE: Considering the difficulties in stopping smoking, this article aimed to identify 
factors relating to failure of attempts to quit smoking among smokers who sought care at an outpatient 
clinic in a general university hospital.
DESIGN AND SETTING: Prospective cohort study evaluating 100 smokers who sought treatment at the 
Psychoactive Substances Outpatient Clinic.
METHODS: The variables gathered were sociodemographic factors; degree of dependence (Fagerström 
questionnaire); stage of motivation for change (University of Rhode Island Change Assessment Scale); and 
presence of depression and anxiety (Hospital Anxiety and Depression Scale). The patients were followed 
up after 4, 8, 12 and 24 weeks to identify factors relating to failure to quit smoking. 
RESULTS: The patients were mostly women (75%), between 40 and 59 years of age (67%); with incomplete 
elementary education (60%); with leisure activities (57%); suffering from tobacco-related disease (53%); 
with previous attempts to quit smoking (70%); with a medical recommendation to stop (51%); with en-
couragement to stop (66%); and with a high degree of dependence (78%). The main motivational stage 
was contemplation/action (43%); the anxiety rate was 64% and the depression rate was 39%. The quitting 
rate was 66% among adherents and 17% among non-adherents (P < 0.001). Lack of success was correlated 
with absence of leisure, higher education and absence of tobacco-related disease.
CONCLUSION: The variables of lack of leisure activities, higher education and/or lack of tobacco-related 
disease correlated with failure to quit smoking among smokers who sought treatment at an outpatient 
clinic in a tertiary general hospital. 
reSUMO
CONTEXTO E OBJETIVO: Considerando as dificuldades na cessação do tabagismo, este artigo objetiva 
identificar fatores relacionados ao insucesso na tentativa de cessação tabágica de fumantes que procura-
ram atendimento em ambulatório de um hospital geral universitário.
TIPO DE ESTUDO E LOCAL: Estudo de coorte prospectivo, que avaliou 100 fumantes que procuraram 
tratamento no Ambulatório de Substâncias Psicoativas.
MÉTODOS: Avaliaram-se variáveis sociodemográficas, grau de dependência (Questionário de Fagerström), 
estágio de motivação para a mudança (University of Rhode Island Change Assessment), presença de 
depressão e ansiedade (Hospital Anxiety and Depression Scale). Os pacientes foram acompanhados em 4, 
8, 12 e 24 semanas para identificar fatores relacionados ao insucesso na cessação do tabagismo. 
RESULTADOS: Os pacientes eram, na maioria, mulheres (75%), entre 40 e 59 anos de idade (67%), com 
ensino fundamental incompleto (60%), com atividades de lazer (57%), portadores de doença tabaco-re-
lacionada (DTR) (53%), com tentativas anteriores de parar de fumar (70%), que receberam recomendação 
médica (51%) e incentivo para a cessação (66%) e com elevado grau de dependência (78%). O estágio de 
motivação principal foi contemplação/ação (43%), a taxa de ansiedade foi de 64% e de depressão, 39%. A 
taxa de cessação foi de 66% entre os que aderiram e de 17% entre aqueles que não aderiram (P < 0,001). 
O insucesso foi relacionado à ausência de lazer, maior escolaridade e ausência de DTR. 
CONCLUSÃO: Falta de atividades de lazer, maior nível educacional e/ou não ter DTR foram variáveis rela-
cionadas ao insucesso na cessação tabágica para tabagistas que procuram tratamento em ambulatório 
inserido em hospital geral terciário.
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INTRODUCTION 
Worldwide, it has been estimated that there are 1.3 billion smok-
ers and that 80% of them live in developing countries.1 Conse-
quently, more than half of the world’s population is exposed, 
directly or indirectly, to the harmful effects of nicotine and other 
toxic substances in tobacco. According to data from the World 
Health Organization (WHO), approximately 700 million chil-
dren are involuntarily exposed to tobacco smoke, especially 
within the home environment, thus increasing the pneumonia 
and bronchitis rates and the risk of sudden death, among other 
diseases.2 Smoking is the leading cause of preventable death 
worldwide and is considered to be a serious public health prob-
lem. In 2009, the WHO estimated that five million deaths were 
attributable to smoking. If current patterns of tobacco use are 
not reversed or the measures provided for global tobacco control 
are not adopted, the projection for 2025 is 10 million deaths.1
In Brazil, smoking affects 17.2% of the population over 15 
years of age.3 Data from the National Cancer Institute indicate 
rates of 200,000 deaths per year, i.e. 23 people die every hour 
because of smoking-related conditions.4
Despite the dissemination of information regarding the dan-
gers of smoking, there are several difficulties in the process of 
breaking an addiction, going from the decision to quit to success 
and persistence in stopping. This difficulty is due to several mech-
anisms, including positive reinforcement (because the action of 
nicotine on the central nervous system results in feelings of plea-
sure, increased disposition, attention and reduced appetite), con-
ditioning (triggered by environmental stimuli and positive and 
negative emotions associated with smoking) and negative rein-
forcement (sustained use to avoid the discomfort of withdrawal 
syndrome symptoms, especially anxiety, dysphoria, increased 
appetite, irritability and difficulty in concentrating).5
The effect of nicotine on the brain and the pharmacologi-
cal and behavioral processes that determine nicotine addiction 
contribute towards the difficulty in maintaining abstinence. The 
symptoms of nicotine withdrawal are the primary reason why 
only 5% to 10% of smokers manage to quit without help.6
The variables associated with success in stopping smoking 
should be considered in strategies for approaching smokers. Sev-
eral studies7 have shown that older men and women, those who 
are married and those with high socioeconomic status all display 
better results relating to stopping smoking. Moreover, the num-
ber of cigarettes smoked per day is also directly related to better 
responses towards attempts to quit smoking.
To optimize the strategies for treating smoking, it is also rel-
evant to discuss the factors related to failure in treating smokers. 
Studies7,8 have shown that high levels of anxiety and depression 
in patients make adherence to and success in treating smoking 
addiction quite difficult, and that starting smoking at an early age 
decreases the likelihood of adherence to treatment.
OBJECTIVE
To identify factors relating to failure in attempts to quit smoking 
among smokers who sought medical care at an outpatient clinic 
in a general university hospital.
METHODS
This was a quantitative, descriptive and prospective cohort study 
that assessed smokers who sought treatment for the first time at 
a specialized clinic in a public university. The subjects were eval-
uated at the time of their first attendance at the clinic and were 
reassessed after 4, 8, 12 and 24 weeks.
The study used convenience sampling, with inclusion of 100 
individuals who visited the Psychoactive Substances Outpatient 
Clinic (Ambulatório de Substâncias Psicoativas, ASPA) of the 
Clinical Hospital, Universidade Estadual de Campinas (HC/Uni-
camp) for the first time between March 2008 and March 2009, in 
order to receive treatment for tobacco addiction.
The inclusion criteria were that the patients could be either 
male or female and that they needed to be over 18 years of age, 
to have been daily smokers for at least six months, to be seeking 
treatment for stopping smoking at ASPA/Unicamp for the first 
time and to have sufficient time to be interviewed before partici-
pating in the initial care at the clinic.
The exclusion criteria were the presence of any cognitive or psy-
chological impairment that prevented understanding of the research 
and/or non-acceptance of the informed consent statement.
Every patient who comes to ASPA because of smoking prob-
lems is routed to a motivation group, which functions as an open 
group, without the need for a formal referral. The group meetings 
for outpatients are held weekly, conducted by the outpatient pro-
fessional team (psychiatrist, pulmonologist, dentist, nurse, social 
worker, psychologist or occupational therapist) and observed 
by postgraduate students, residents and public health provid-
ers under training. The group meetings are one hour in length 
and the topics of discussion include the difficulties in quitting, 
mechanisms relating to nicotine addiction, barriers against stop-
ping, treatment alternatives and strategies for recognizing per-
sonal motivators for stopping smoking. After a patient has par-
ticipated in at least four group sessions and is motivated to move 
forward in the process, he/she is instructed to complete an indi-
vidual assessment prior to inclusion in the therapeutic group.
We used two semi-structured questionnaires (one for the ini-
tial assessment and one for the follow-up at weeks 4, 8, 12 and 
24) and five psychometric instruments, all applied individually 
by the first author of the study, as described below.
•	 Initial	assessment	file:	this	included	a	survey	of	sociodemo-
graphic data (gender, age, employment status, education 
level, origin, marital status, children, age of the children, peo-
ple who the patient was living with, leisure activities, religion 
and religious practice), clinical data (whether the patient had 
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any physical illnesses and what type; mental illnesses and 
what type; whether the patient was consuming alcohol and 
how often; and what use was made of other psychoactive sub-
stances) and data relating to the recommendation to come to 
the clinic.
•	 Fagerström	addiction	questionnaire:9,10 this consisted of six 
questions that evaluated tobacco addiction, with scores rang-
ing from 0 to 10. These scores were used to classify depen-
dence as low, medium or high.
•	 University	 of	 Rhode	 Island	 Change	 Assessment	 Scale	
(URICA):11,12 this scale evaluated the stage of action for 
change.	 It	 consists	 of	 32	 items	divided	 into	 four	 subscales:	
precontemplation, contemplation, action and maintenance. 
This scale can be used to evaluate any addictive behavior, and 
has previously been validated and adapted for the Brazilian 
population.
•	 Hospital	Anxiety	and	Depression	Scale	(HAD):13,14 this scale 
was primarily designed to detect mild degrees of depression 
and anxiety among non-psychiatric patients in a general hos-
pital. Patients are asked to answer based on how they felt dur-
ing the preceding week. In the current study, a cutoff value of 
8/9 was used.
•	 Semi-structured	 questionnaire	 for	 data	 on	 smoking:	 this	
investigated the history of tobacco use; whether the patient 
was living with smokers; whether the patient had had any 
tobacco-related health problems; data on previous attempts 
to quit, i.e. whether it had previously been attempted and 
how often it had been attempted; and data on motivation to 
stop smoking, i.e. whether there had been any encourage-
ment, who had provided the main encouragement, the fam-
ily’s reaction to the decision to stop and what motivated the 
decision to stop smoking.
•	 Follow-up	 questionnaire:	 a	 semi-structured	 questionnaire	
was applied in the 4th, 8th, 12th and 24th weeks after the first 
interview. The questionnaire investigated patient attendance 
at care services, adherence or non-adherence to treatment 
and outcome (i.e. whether the patient stopped, reduced, 
increased or maintained smoking, or relapsed).
We also identified tobacco-related comorbidities that were 
mentioned	 by	 patients:	 cardiovascular	 diseases	 (hyperten-
sion, atherosclerosis, angina, myocardial infarction, stroke and 
thromboangiitis obliterans), respiratory conditions (chronic 
bronchitis, emphysema, pneumothorax, congestive cardiorespi-
ratory, asthma and respiratory infections) and cancers (in the 
lungs, mouth, tongue, pharynx, larynx, esophagus, stomach, 
pancreas, liver, bladder, colorectum, prostate, skin and lym-
phoid cells).15
Patients who attended the motivational group meetings but 
did not begin attending the therapeutic group meetings were 
deemed to present non-adherence to treatment. Patients who 
had not stopped smoking at follow-up assessments (weeks 4, 
8, 12 and 24) were deemed to present therapeutic failure. The 
results presented in this article refer to the outcomes evaluated at 
the end of the 24th week of the follow-up. The criterion for adher-
ence	 to	 treatment	was	preestablished:	patients	were	considered	
to be adherent to treatment when they attended the motivational 
group sessions at least four times.
Patients who sought ASPA to obtain treatment for tobacco 
addiction during the study period and who arrived at the clinic 
at least 20 minutes prior to the group motivational session were 
asked whether this was their first time seeking this service. When 
the answer was affirmative, they were invited to participate in 
the study through providing them with an explicit descrip-
tion of its goals and allowing them to read the informed con-
sent statement. Those who did not arrive for the first day of treat-
ment early enough to be interviewed prior to the group meeting 
were excluded. The aim in choosing not to include in the study 
patients who were not seeking ASPA for the first time and not to 
conduct interviews after the group motivational session was to 
avoid using terms that patients in this group had learned and to 
avoid situations in which the patients had learned not to express 
their	spontaneous	motives.	For	patients	who	were	included	in	the	
survey, after they had agreed to participate, the aforementioned 
tools were administered. 
To perform the follow-up, the researcher contacted the 
patients in an outpatient setting at the end of the visits. When 
the patient did not attend the clinic on the scheduled day of 
their follow-up interview (weeks 4, 8, 12 or 24), telephone calls 
were made to ask them to come to the clinic during the fol-
lowing week. If telephone contact was not possible, the follow-
ing	measures	were	used:	telephone	directory	aided	by	Internet	
search; and assistance from the Social Services of the Clini-
cal Hospital of Unicamp. After three requests for attendance, 
if the patient did not visit the clinic, a follow-up interview 
was conducted by telephone. If both measures were unsuc-
cessful, the patient was considered to have been lost from the 
follow-up.
This	study	was	approved	by	the	Research	Ethics	Committee	
of Unicamp under registration number 0690.0.146.000-07.
The data gathered were entered into the SAS software data-
base (SAS – Statistical Analysis Systems, version 9.1.3., 2002-
2003). To analyze the relationship between categorical vari-
ables,	the	chi-square	test	or	the	Fisher	exact	test	(for	expected	
values lower than 5) was used. To analyze non-adherence and 
therapeutic	failure	outcomes,	the	Cochran	and	Friedman	tests	
were used. To study the factors associated with treatment fail-
ure at week 24, logistic regression analyses, univariate models 
and multivariate models with stepwise criteria of variable selec-
tion were used. The significance level for statistical tests was 5% 
(P < 0.05).
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RESULTS
During the study period, 281 people sought treatment for tobacco 
addiction at the Psychoactive Substances Outpatient Clinic of the 
Clinical Hospital, Unicamp. Of these, 151 people did not arrive for 
the first day of treatment sufficiently early to be interviewed prior 
to	the	group	meeting	and	were	not	included	in	the	study.	Further-
more, 28 subjects had previously been patients at the clinic and 
were making a new attempt because of a relapse, and were there-
fore excluded. Two subjects were excluded due to psychological or 
cognitive	 impairment:	one	showing	significant	cognitive	 impair-
ment and the other showing symptoms of intoxication during the 
interview. Thus, we evaluated 100 smokers who sought treatment 
to stop smoking for the first time at ASPA (Figure 1).
There was a loss of 11% of the patients over the subsequent six 
months. The highest rates of loss were concentrated within the first 
and fourth weeks (5%) and from the 12th to the 24th week (5%).
Of the smokers evaluated in this study, the majority (64%) 
had begun smoking before reaching 15 years of age and 72% had 
smoked for 30 years or more.
Other data relating to the patients’ profile are shown in Table 1.
Table 2 presents the profiles of the patients who succeeded in 
stopping and failed to stop smoking after six months.
The quitting rate was 66% among those who adhered to the 
treatment and 17% among those who did not adhere (P < 0.001). 
The criterion for compliance was at least four weeks in group 
motivational sessions. The reasons given for noncompliance 
were often difficulty in finding time (27% of the patients), diffi-
culty in obtaining transportation (5%) or personal health prob-
lems (8%). 
The variables included in logistic regression analysis on the 
failure to quit smoking were gender, age, education level, pro-
fessional status, marital status, living with smoker, leisure activ-
ities,	 religion,	 religious	 practice,	 tobacco-related	 disease,	 Fag-
erström,	 URICA,	 HAD	 for	 depression	 and	 anxiety	 and	 main	
encouragement. 
The results from multivariate logistic regression analysis indi-
cated that the variables of tobacco-related disease, leisure and edu-
cation level were significantly associated with treatment failure at 
24 weeks. Moreover, the subjects with a high risk of failure were 
those without tobacco-related disease (2.7 times), without leisure 
(3.9 times) and with higher education (4.5 times) (Table 3).
DISCUSSION
The main objective of this study was to investigate factors asso-
ciated with failure to quit smoking, among a group of smokers 
who sought treatment at a specialized clinic. Our intention was 
to contribute towards increasing the quitting rate based on iden-
tifying factors that influence the failure to quit smoking.
The sociodemographic profile of the smokers who sought 
treatment was that they were mostly women, within the age 
range of 40 to 59 years; they lacked complete elementary education, 
were employed, were Catholic and had a partner. This is compatible 
with data from the Brazilian literature.16 These data suggest that stud-
ies addressing two aspects of treating tobacco addiction are impor-
tant:	the	reasons	why	lower	rates	of	men	seek	treatment	(even	though	
the prevalence of smoking is higher among males); and the need to 
develop strategies to raise smokers’ awareness that they should seek, 
and health professionals’ awareness that they should recommend, 
Figure 1. Monitoring of patients during the study.
 
 
Total demand for treatment = 281
Excluded = 2*
Ex-patients = 28
Without timely arrival = 151  
Week 4
Losses = 5
n = 95
Adhered: 67 (71%) 
Reduced number of cigarettes 37 (39%)
Stopped smoking 6 (6%)
 
 
Week 8 
Losses = 1
n = 94
Adhered: 54 (57%)
Reduced number of cigarettes 33 (35%)
Stopped smoking 17 (18%) 
 
Week 12
Losses = 0
n = 94
Adhered: 51 (54%)
Reduced number of cigarettes 25 (27%)
Stopped smoking 30 (32%) 
Week 24
Losses = 5
n = 89
Adhered: 32 (36%) 
Reduced number of cigarettes 8 (9%)
Stopped smoking 31 (35%) 
 
Initial assessment
n = 100
 
*for psychological or cognitive impairment.
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treatment at an earlier age. Through this, the harmful conse-
quences relating to long-term exposure to cigarette smoke may 
be minimized.
In terms of smoking history, most of the patients in this study 
started the habit at 15 years of age or younger, had smoked for 
30 years or more and had a high degree of addiction accord-
ing	to	the	Fagerström	test.	These	data	are	consistent	with	other	
work in this field.17 Moreover, most of the patients had previously 
attempted to quit smoking and had been encouraged to do so 
and seek treatment. This may indicate that this was a subgroup of 
patients with greater chances of success.7
The data from this study emphasize the harmful conse-
quences of smoking,15 such as the high rates of tobacco-related 
disease,	 with	 prevalence	 of	 respiratory	 diseases.	 Furthermore,	
approximately one-third of the patients were off work or had 
retired due to illness. Moreover, it is possible that because of 
their diseases, such individuals may have received more encour-
agement from physicians and other health professionals to stop 
smoking because they used greater quantities of health services 
in addressing their health problems.18
The comorbidity rates relating to depression and anxiety, eval-
uated using the HAD Scale (39% and 64%, respectively), were 
higher than the rates for the population in general.19 These variables 
were not associated with the outcome studied, probably because of 
the limitations imposed by the number of subjects. However, it is 
important for these comorbidities to be assessed by healthcare pro-
fessionals, with the aim of achieving a broader approach to tobacco 
addiction.
One study20 has suggested that lower rates of compliance with 
treatment are directly associated with lower rates of abstinence 
from smoking. In the current study, success in stopping smoking 
was significantly higher among those who adhered to the treat-
ment (66% versus 17% among non-adherents). The relationship 
between adherence and success indicates the importance of stud-
ies that contribute towards optimizing the adherence strategies. 
Moreover, this finding suggests that there is a need for studies to 
deepen the understanding of success rates higher than the spon-
taneous quitting rate (around 5% to 10%),6 even among patients 
who do not adhere to treatment.
The quitting rate of 35% in this study is similar to the find-
ings in other Brazilian and international studies.17,21 This result 
should encourage expansion of services for smokers, so as  to 
contribute towards reducing the morbidity-mortality associated 
with tobacco.
One factor that was related to treatment failure in the multi-
variate analysis was the lack of leisure activities. It was shown in 
one study22 that participation in meetings outside of the work-
place, at church or with family members was predictive of suc-
cess among daily smokers, thus suggesting that social participa-
tion promotes successful treatment for smokers. Another study18 
Variable n %
Sex  
Female 75 75%
Male 25 25%
Age group
≤ 39 years  21 21%
40-59 years 67 67%
≥ 60 years 12 12%
Educational level 
≤ Elementary uncompleted 60 60%
≥ Elementary complete 27 27%
Professional status
Working 53 53%
Off work because of illness 20 20%
Retired due to illness 11 11%
Unemployed 9 9%
Marital status 
With partner 54 54%
Without partner 46 46%
Living with smoker 43 43%
With leisure activities 57 57%
With tobacco-related disease (n = 53) 
Respiratory  30 55%
Cardiovascular  13 24%
Cancer 10 18%
Attempted to quit previously 70 70%
Recommendation  
Doctor  51 51%
Others 44 44%
Fagerström
High 78 78%
Medium or low 22 22%
Received encouragement to quit 66 66%
URICA 
Contemplation 36 36%
Contemplation/action  43 43%
Action 21 21%
HAD anxiety-positive 64 64%
HAD depression-positive 39 39%
Main reasons for non-adherence (n = 57)
Schedule difficulty 27 47%
Personal problems 6 10%
Transport 5 9%
Lack of interest 5 9%
Table 1. Profile of the study population (n = 100)
URICA = University of Rhode Island Change Assessment; HAD = Hospital Anxiety 
and Depression Scale 
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reported that smokers who engaged in other activities in their 
routine and did not need to smoke to pass the time had greater 
success in the treatment. This indicates that there is a need to 
integrate strategies considering this variable, in order to facilitate 
stopping smoking.
The second noteworthy factor associated with failure was 
a higher education level. This finding was not corroborated by 
other studies,23 which showed an inverse relationship. It is likely 
that this finding relates to the fact that the present study evalu-
ated individuals who sought treatment at a public university hos-
pital with a care profile characterized by high demand, limited 
space and participation of students and other professionals in 
training as observers. In addition, the language adopted in the 
groups indicated that most participants in this study had a low 
educational profile. However, other studies, particularly among 
Brazilian populations, should be undertaken in order to exam-
ine this hypothesis.
One factor cited in the multivariate analysis as associated 
with failure to quit smoking was the absence of tobacco-related 
disease. A recent study24 noted that the presence of tobacco-re-
lated disease was correlated with seeking treatment and pre-
senting	 greater	motivation	 to	 quit.	 From	 these	 data,	 it	 can	 be	
suggested that smokers could be targeted with greater empha-
sis on the benefits associated with prevention of tobacco-re-
lated disease, as well as the quality-of-life benefits from stopping 
smoking, even before the emergence of any disease related to 
smoking.
Some limitations of this study should be highlighted. The 
first relates to the small number of subjects evaluated, which lim-
ited the power of statistical analysis. Another limitation was the 
non-inclusion of individuals who did not arrive on the first day 
with sufficient time to undergo the interview before their par-
ticipation in the host group. Although this method prevented us 
from including a significant number of smokers in the study, it 
was used because we considered it to be more important for the 
patients not to be compromised in their search for treatment (i.e. 
by not starting their care on the desired day) as a result of our 
research project. A further limitation was that stopping smoking 
was measured through self-reporting, without biological valida-
tion	such	as	serum	cotinine	measurement.	Finally,	it	is	important	
to mention that the study was conducted using a convenience 
sample (a population that sought treatment with voluntary com-
pliance), which imposes limitations on extrapolating the data to 
different populations.
CONCLUSION
The variables of lack of leisure activities, higher education and/
or absence of tobacco-related disease were correlated with failure 
to quit smoking, among smokers who sought medical care at an 
outpatient clinic in a tertiary general hospital. 
Variable n Failure (%) Success (%) P
Total 89* 58 (65) 31 (35)
Sex  
Female  67 43 (74) 24 (77)
0.7
Male 22 15 (26) 7 (23)
Age group
< 50 years  45 30 (52) 15 (48)
0.7
≥ 50 years 44 28 (48) 16 (52)
Schooling
≤ Elementary uncompleted 67 40 (69) 27 (87)
0.05
≥ Elementary complete 22 18 (31) 4 (13)
Professional status 
Working 48 33 (57) 15 (48)
0.4
Unemployed 41 25 (43) 16 (52)
Marital status  
With partner  48 31 (53) 17 (55)
0.9
Without partner 41 27 (47) 14 (45)
Living with smoker
Yes 39 28 (48) 11 (35)
0.2
No 50 30 (52) 20 (65)
Leisure activities 
With leisure activities 50 28 (48) 22 (71) 0.04
Without leisure activities 39 30 (52) 9 (29)
Tobacco-related disease (n = 53) 
With tobacco-related disease  48 26 (45) 22 (71)
0.01
Without tobacco-related disease 41 32 (55) 9 (29)
Attempted to quit previously 
Yes 61 38 (66) 23 (74)
0.4
No 28 20 (34) 8 (26)
Recommendation
Doctor 49 31 (53) 18 (58)
0.1
Others 40 27 (47) 13 (42)
Fagerström 
High 68 44 (76) 24 (77)
0.8
Medium or low 21 14 (24) 7 (23)
Received encouragement to quit 60 41(71) 19 (61) 0.3
URICA 
Contemplation 32 23 (40) 9 (29)
0.3Contemplation/action 38 25 (43) 13 (42)
Action 19 10 (17) 9 (29)
HAD anxiety-positive 58 38 (66) 20 (64) 0.9
HAD depression-positive 35 24 (59) 11 (35) 0.5
*Losses over the course of the monitoring (n = 11).
Table 2. Profile of failure and success regarding quitting smoking
Variable P OR 95% CI
Leisure
Yes  
0.010 3.91 1.39-11.01
No
Education 
≤ Elementary 
0.024 4.51 1.22-16.58
> Elementary
Tobacco-related disease 
Yes 
0.049 2.70 1.01-7.25
No
OR = odds ratio; CI = confidence interval.
Table 3. Multiple regression analysis on factors for failure to quit 
smoking at 24 weeks
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